Free Trial

Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 0.4% - What's Next?

Bayer Aktiengesellschaft logo with Medical background

Shares of Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) fell 0.4% during mid-day trading on Thursday . The company traded as low as €26.18 ($28.46) and last traded at €26.43 ($28.73). 3,972,932 shares were traded during mid-day trading, The stock had previously closed at €26.53 ($28.84).

Bayer Aktiengesellschaft Price Performance

The company has a market cap of $25.97 billion, a PE ratio of -20.49, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a debt-to-equity ratio of 129.94, a quick ratio of 0.72 and a current ratio of 1.27. The stock has a 50 day moving average of €27.96 and a 200-day moving average of €27.52.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Bayer Aktiengesellschaft right now?

Before you consider Bayer Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.

While Bayer Aktiengesellschaft currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Billionaires Bet Big on Cavco and Champion Homes
3 Momentum Stock Picks With Room to Run
Champion Homes’ 37% Sales Surge: Time to Invest?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines